Global overview and regional protocols for molecular diagnosis of human T-cell lymphotropic virus
Open Access
- 17 November 2026
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
Abstract
Human T-cell lymphotropic virus type-1 (HTLV-1) has been recognized as an infection of global importance by the World Health Organization (WHO) in their published HIV, Hepatitis, and STI Global Health Sector Strategy 2022-2030 ; however, there are no commercial molecular assays for HTLV-1 available globally. While some countries are strengthening their efforts to diagnose HTLV-1 and prevent transmission (i.e., Brazil introduced universal antenatal screening in 2024), the prevalence of HTLV-1 in many parts of the world is unknown. Unsurprisingly, there is great inequity in access to molecular HTLV testing services, which can importantly contribute both as part of a diagnostic confirmatory testing algorithm and be used to monitor disease. Due to the lack of commercially available molecular assays, laboratories rely on in-house developed protocols, resulting in substantial variability in methodologies and access to testing. An HTLV Testing Working Group was established by the International Retrovirology Association in 2023 with the objective to improve access to and the quality of molecular testing for HTLV-1 globally. Representatives from nine laboratories in Argentina, Australia, Brazil, Iran, Japan, Sweden, and the United Kingdom have collaboratively compared their in-house molecular protocols. The methods are presented and summarized with a discussion of the relative strengths and limitations of each platform and key considerations for laboratories establishing molecular HTLV testing capacity. This analysis provides a practical framework supporting equitable expansion of HTLV molecular diagnostics globally, aiming to help countries with varying access to funding to be able to select the assay best suited to their means while recognizing the relative risks and benefits.This publication has 56 references indexed in Scilit:
- Screening for HTLV-1 infection should be expanded in EuropeInternational Journal of Infectious Diseases, 2024
- The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq ApproachCell Reports, 2019
- Serological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection2017
- The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell linesHuman Cell, 2016
- Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutationsJournal of NeuroVirology, 2014
- Human T-lymphotropic virus type 1 infection is frequent in rural communities of the southern Andes of PeruInternational Journal of Infectious Diseases, 2014
- High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology surveyJournal of Clinical Virology, 2011
- Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: Addressing the issue of indeterminate HTLV resultsJournal of Clinical Virology, 2011
- TaqMan real-time PCR versus four conventional PCR assays for detection of apple proliferation phytoplasmaPlant Molecular Biology Reporter, 2006
- Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of ‘nested’ PCR productsJournal of Virological Methods, 1992